MVA CEO, Petter Hartman, calls for more “financial muscle” to support early-stage life science in Sweden

Nov 24, 2020

Swedish life science is expanding, but there are still bottleneck to be adressed. As a result of the lack of financial muscle life science companies sometimes IPO to early. A public 1.000.000.000 SEK fund could be part of the solution, Petter Hartman argues in today´s edition of Life Science Sweden (Article in Swedish)

Most recent news